PIM1 has also been linked to a variety of oncogenic processes in both prostate cancer and other cancers, including cell-cycle progression, genomic instability, resistance to chemotherapeutics, and increased tumorigenicity in mouse xenograft models2–6. Here, PIM1 is linked to prostate cancer.